- Market Capitalization, $K 201,563,808
- Shares Outstanding, K 2,291,800
- Annual Sales, $ 48,677 M
- Annual Income, $ 11,732 M
- 60-Month Beta 0.64
- Price/Sales 4.35
- Price/Cash Flow 11.54
- Price/Book 3.72
|Period||Period Low||Period High||Performance|
| || |
-6.76 (-7.20%)since 01/24/20
| || |
-5.01 (-5.44%)since 11/26/19
| || |
+6.63 (+8.24%)since 02/26/19
An analysis of Global has been provided within the latest report launched by Big Market Research that primarily focuses on the market trends, demand spectrum, and future prospects of this industry over...
Global 2020-2025 research report is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges with key company profiles and strategies of players....
The report offers a comprehensive analysis of the market. This report focused on market past and present growth globally. Global research on Global Epilepsy Therapeutics Industry presents a market overview,...
Global Adult Vaccines Market (Revenue and Volume), Type, Application, End-User, and Regional Analysis, Import-Export Analysis, Industry Analysis, Premium Insights, Intellectual Property Analysis, Market...
- Filings are supported by Phase III ASCLEPIOS I and II studies, where ofatumumab showed highly significant and clinically meaningful reduction in the number of confirmed relapses, evaluated as annualized...
Genetron Holding Limited ("Genetron Health"), a China-based precision oncology company that covers full-cycle cancer care, has announced a strategic partnership with Beijing InnoCare Pharma Tech Co., Ltd....
AstraZeneca's (AZN) Q4 results were disappointing. European Commission approves Novartis (NVS) and Pfizer's (PFE) new drugs.
Puma Biotech (PBYI) incurs narrower loss in Q4 and tops sales estimates. Sales of Nerlynx decline year over year. Stock drops 10%.
Intellia (NTLA) is likely to provide an update on the IND application for its lead candidate NTLA-2001, currently being developed to address transthyretin amyloidosis.
|Value Line Dividend Idx First Trust|
|Intl Dividend Achievers Invesco ETF|
|Pharmaceutical Vaneck ETF|
|Advisorshares Dorsey Wright ADR|
|Bldrs Developed Markets 100 ADR Index Fund Inves|